trial

Bilateral Prefrontal and Insular TMS for Depression in Schizophrenia

NCTId NCT07060066
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Recruiting
Enrollment 120 (estimated)
Sponsored by The University of Texas Health Science Center, Houston
Primary completion 2030-06-01
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Recruiting
Enrollment
120 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Double
Start
2024-05-21
Primary completion
2030-06-01
Eligibility
ALL · 18 Years · 60 Years

Interventions & indications

Drugs
Active rTMS stimulation

Sponsors

The University of Texas Health Science Center, HoustonLead Sponsor
National Institute of Mental Health (NIMH)Collaborator

Investigators

1
Xiaoming Du, PhDPrincipal Investigator

Sites

1 total
Houston, United States

Facts & assertions

4 sourced
Enrollment
120
Phase
NA
Primary Completion Date
2030-06-01
Status
RECRUITING
relationships
The graph out of here
drug
Active rTMS stimulation
drug
lead_sponsor
The University of Texas Health Science Center, Houston
company
collaborator
National Institute of Mental Health (NIMH)
company
indication
Schizophrenia and Related Disorders
indication
Depression
indication
Schizophrenia
indication
investigator
Xiaoming Du, PhD
person